NEW YORK (TheStreet) -- RATINGS CHANGES
Cree (CREE) was upgraded to buy at TheStreet Ratings.
Guess (GES) was initiated with a buy rating at Wunderlich. $31 12-month price target. New leadership can turn the domestic business around, said Wunderlich.
Intercept Pharmaceuticals (ICPT) was upgraded to hold at TheStreet Ratings.
Intermune (ITMN) was downgraded to neutral from buy at Goldman Sachs. This was a valuation call, based on a $49 12-month price target, said Goldman.
Madison Square Garden (MSG) was downgraded to hold from buy at Topeka Capital. $63 12-month price target. The company may fail to meet levered free cash flow expectations in 2015, Topeka said.
Tivo (TIVO) was upgraded to buy at TheStreet Ratings.
Editor's note: To see analysts' stock comments and changes to price targets and earnings estimates, go to "Street Notes" which is available only to Real Money subscribers. To find out how to become a subscriber, please click here.
TheStreet Ratings team rates TIVO INC as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation:
"We rate TIVO INC (TIVO) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, notable return on equity, reasonable valuation levels and compelling growth in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook."
Highlights from the analysis by TheStreet Ratings Team goes as follows: